SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-037097
Filing Date
2022-02-11
Accepted
2022-02-11 16:19:04
Documents
1
Group Members
ABG MANAGEMENT LTD.ALLY BRIDGE GROUP (NY) LLCALLY BRIDGE MEDALPHA MANAGEMENT GP, LLCALLY BRIDGE MEDALPHA MANAGEMENT L.P.FAN YU

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d296858dsc13ga.htm SC 13G/A 120916
  Complete submission text file 0001193125-22-037097.txt   123104
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88625 | Film No.: 22621273
SIC: 8071 Services-Medical Laboratories

Mailing Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000
Business Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000 852 31219699
Ally Bridge MedAlpha Master Fund L.P. (Filed by) CIK: 0001831963 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A